Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the-shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera's versatile platform shows promise in broader immunomodulation applications.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Ottawa, On, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://EspheraSynBio.ca
- Keywords
- Specialist jobs.
- HQ
- Ottawa, ON
Esphera Synbio Inc Questions
Esphera Synbio Inc's website is http://EspheraSynBio.ca
Esphera Synbio Inc's LinkedIn profile is https://ca.linkedin.com/company/esphera-synbio-inc
Esphera Synbio Inc has
11 employees.
View email and phone details for 11
employees at Esphera Synbio Inc.
Esphera Synbio Inc's industry is
Biotechnology Research
Esphera Synbio Inc's top competitors are
Jn Nova,
Prosilience Biotech,
Obio,
Yellowbird Diagnostics, Inc.,
Virano Therapeutics,
Hylid Diagnostics Inc,
Turnstone Biologics,
Rhythm Biotherapeutics Inc.,
Nuvobio,
Capital Bioventures.
Esphera Synbio Inc's categories are Biotechnology Research
Esphera Synbio Inc's founding year is 2022
